1) glucocorticoid receptor blocking pharmacon
糖皮质激素受体抑制剂
2) glucocorticoid receptor antagonist
糖皮质激素受体拮抗剂
1.
Methods:The rats were randomly divided into 5 groups as follows:① rats with no medication receiving only normal saline (normal control,group A);②the rats were injected subcutaneously with dexamethasone (5 mg/kg,group B);③ rats were injected subcutaneously with dexamethasone (15 mg/kg,group C);④ rats were treated with glucocorticoid receptor antagonist RU38486 (10 mg/kg) by gavage (g.
方法 :将大鼠随机分为5组 :1正常对照组 (A组 ) ;2皮下注射地塞米松 5 mg/kg组 (B组 ) ;3皮下注射地塞米松 15 mg/kg组(C组 ) ;4糖皮质激素受体拮抗剂 RU 384 86 (10 mg/kg)灌胃组 (D组 ) ;5皮下注射地塞米松 (15 mg/kg)前 2小时 RU 384 86 (10 mg/kg)灌胃组 (E组 )。
3) glucocorticoid receptor
糖皮质激素受体
1.
Mechanism for decrease of glucocorticoid receptor mRNA in human hepatic cancer cell line SMMC-7721 during heat shock;
热休克抑制人肝癌SMMC-7721细胞糖皮质激素受体mRNA表达及其机制探讨
2.
Study on glucocorticoid receptor in early stage of multiple trauma;
糖皮质激素受体在多发伤后早期作用的研究
3.
Advances in study of glucocorticoid receptor induced insulin resistance and its antagonists;
糖皮质激素受体介导的胰岛素抵抗及其拮抗剂研究进展
4) GR
糖皮质激素受体
1.
Influence of Electroacupuncture on the Expression of GR and NR2B in Hippocampal of Chronic Stress Depression Model Rats;
电针对慢性应激抑郁模型大鼠海马糖皮质激素受体和N-甲基-D-天冬氨酸受体2B表达的影响
2.
The Development of GR Blockade Model in Chicken;
鸡糖皮质激素受体阻断模型的建立
3.
Objective To study the effect of burn injury on the expression of glucocorticoid receptor (GR) and its nuclear translocation in SRC-3 knock out mice.
目的研究严重烧伤早期SRC-3基因敲除小鼠肝脏糖皮质激素受体表达及核转位的变化。
5) Glucocorticoid receptor(GR)
糖皮质激素受体
1.
Objective To observe the changing characteristics of cochlear glucocorticoid receptor(GR) expression after acute hypoxia.
目的观察缺氧后早期豚鼠耳蜗糖皮质激素受体(glucocorticoid receptor,GR)的变化特点。
2.
Objective To study the correlation between the rabbit glucocorticoid receptor(GR) and steroid induced glaucoma(SIG).
目的 研究家兔糖皮质激素受体 (GR)与激素性青光眼 (SIG)的关系。
6) adrenocortical inhibitor
皮质激素抑制剂
补充资料：皮质激素抑制剂
分子式：
CAS号：
性质：肾上腺皮质激素生成合成抑制剂有甲吡酮、氨基民眠能，双氯苯二氯乙烷。它们作用于皮质激素合成的不同环节和部位。临床上用于皮质醇过多症和垂体-肾上腺皮质系统功能检查。
CAS号：
性质：肾上腺皮质激素生成合成抑制剂有甲吡酮、氨基民眠能，双氯苯二氯乙烷。它们作用于皮质激素合成的不同环节和部位。临床上用于皮质醇过多症和垂体-肾上腺皮质系统功能检查。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条